Koyfin Home > Directory > Health Care > Kiniksa Pharmaceuticals Ltd > Enterprise Value

Kiniksa Pharmaceuticals Ltd Enterprise Value Chart (KNSA)

Kiniksa Pharmaceuticals Ltd annual/quarterly Enterprise Value from 2018 to 2020.
  • Kiniksa Pharmaceuticals Ltd Enterprise Value for the quarter ending November 11, 2020 was $907m a 12.23% increase of 111m year over year
  • Kiniksa Pharmaceuticals Ltd Enterprise Value for the last 12 months ending November 11, 2020 was $907m a 12.23% increase of 111m year over year
  • Kiniksa Pharmaceuticals Ltd Annual Enterprise Value for 2020 was $907m a 3.00% increase of 27m from 2019
  • Kiniksa Pharmaceuticals Ltd Annual Enterprise Value for 2020 was $880m a 4.33% increase of 38m from 2019
  • Kiniksa Pharmaceuticals Ltd Annual Enterprise Value for 2020 was $842m a 5.42% increase of 46m from 2019
View Chart On Koyfin

Quarterly KNSA Enterprise Value Data

11/2020$907m
11/2020$880m
11/2020$842m
11/2020$796m
11/2020$692m
11/2020$650m
11/2020$653m
11/2020$645m
11/2020$674m
11/2020$721m

Annual KNSA Enterprise Value Data

2020$907m
2020$880m
2020$842m
2020$796m
2020$692m
2020$650m
2020$653m
2020$645m
2020$674m
2020$721m